For each cancer type, we searched for matching gene expression and copy number datasets of at least three patients carrying homozygous deletions of these four genes (PAPSS2, ATAD1, KLLN, and PTEN) without considering other factors, such as tumor grade, age, or gender of the patients. This evidence concerns the gene PTEN and cancer.